i. 'The company has entered into an Agreement with Allencure Biotech Pvt Ltd to sell the Factory Land located at Vllage Nagal, Kala Amb, Tehsl Nahan, Distt Sirmour, Himachal Pradesh against which cosideration of Rs 90 00 lakhs has been received in F Y. 2021*22 and Further payment of Rs 50 00 lakhs has been received in FY 2022-23. As on 31st March 2025, the title of the property is in the name of the company i e, registry is yet to be done in the favour of Allencure Biotech Pvt Ltd.

ii During the year 2023-24 company has entered into an agreement to sell its property located at SIPCOT, Ranipet Chennai against which consideration of Rs. 3 00 crore has been receiver from the M/s Value Mount Lixiviate Pri\ate Limited and further payment of Rs 5.75 crore has been received during FY 2024-2!

Iii. During the year 2024-25 company has entered into an agreement to sell its property located at Chhata, Mathura against which consideration of Rs. 3.82 crore has been received from the M/s Vrinda Reality.

iv. During the year 2024-25 company has entered into an agreement to sell its property located at Chhata, Mathura against which consideration of Rs. 0.50 crore has been received from the M/s Bankey Bihari Developers

v During the year 2024-25 company has entered into an agreement to sell its property located at Chhata. Mathura against which consideration of Rs 0 25 crore has been received from the M/s M S Urban Buildcon.

A. Terms/rights attached to Equity Shares

(i)    The company has only one class of equity shares hairing par value of Rs. 10 per share Each holder of equity shares is entitled to one vote per share The company declares and pays dividends in Indian rupees The dividend, if any, proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual General Meeting

(ii) ln the event of liquidation of the company, the holders of equity shares will be entitled to receive remaining assets of the company, after distrbutionof all preferential amounts The distribution will be in proportion to the number of equity shares held by the shareholders

B Terms/rights attached to Preference Share redeemable after 8 years

(i)    Redeemable Non Convertible Preference shares shall carry a preference dividend at the rate of 0.5% per annum, payment of dividend shall be on cumulative basis at the time of redemption and the preference shares shal be redeemable on completion of 8 years from the date of allotment at premium of 400% of the Face Value of the preference shares.

(ii) In the event of liquidation of the company, the holders of redeemable non convertfele preference shares shall be non-participating in surplus funds and in surplus assets and profits, on winding-up which may remain after the entire capital has been repaid

C Terms/rights attached to Preference Share redeemable after 4 years

(i)    Redeemable Non Convertible Preference shares shall carry a preference diwdend at the rate of 0.5% per annum, payment of dividend shall be on cumulative basis at the time of redemption and the preference shares shal be redeemable on completion of 4 ^ars from the date of allotment at premium of 700% of the Face Value of the preference shares.

(ii) In the event of liquidation of the company, the holders of redeemable non convertible preference shares shall be non-participating in surplus funds and in surplus assets and profits, on winding-up which may remain after the entire capital has been repaid

i.    The company has entered into an Agreement with Allencure Biotech Pvt Ltd to sell the Factory Land located at Vllage Nagal, Kala Amb, Tehsl Nahan, Disrt Sirmour, Himachal Pradesl against which coside ration of Rs. 90.00 lakhs has been received in F Y 202L-22 and Further payment of Rs. 50.00 lakhs has been received in FY 2022-23. Ason 31st March 2025, the title of the property is in the name of the company i.e, registry is yet to be done in the favour of Allencure Biotech Pvt Ltd.

ii.    Duringthe year 2023-24 company has entered into an agreement to sell its property located at SIPCDT, Rampet Chennai against which consideration of Rs. 3.00 crore has been receive! from the M/s. Value Mount Lixiviate Private Limited and further payment of Rs. 5.75 crore has been received during FY 2024-25

Hi. During the year 2024-25 company has entered into an agreement to sell its property located at Chhata, Mathixa against which consideration of Rs. 3.82 wore has been received from the M/s. Vrinda Reality.

iv.    During the year 2024-25 company has entered into an agreement to sell its property located at Chhata, Mathira against which consideration of Rs. 0.50 crore has been received from the M/s. Bankey Bihari Developers.

v.    Duringthe year 2024-25 company has entered into an agreement to sell its property located at Chhata, Mathura against which consideration of Rs. 0.25crore has been received from the M/s. MS Urban Buildcon.

Note: All the Claims against the company / disputed liabilities which was not acknowledged as debt except as shown above has been reduced to zero (NIL) on pursuant to the order of Hon'ble NCLT approving the resolution plan submitted by Feeders Holding Limited (Formerly Known as IM+ CAPITALS LTD).

35)    PURSUANT TO THE RESOLUTION PLAN SUBMITTED BY THE FEEDERS HOLDING LIMITED (FORMERLY KNOWN AS IM+ CAPITALS LIMITED!. AND ITS APPROVAL BY THE HON ABLE NATIONAL COMPANY LAW TRIBUNAL. VIDE THEIR ORDER DATED 06^th OCTOBER 2021. OTHERWISE AS STATED IN BELOW NOTES. THE FOLLOWING CONSEQUENTIAL IMPACTS HAVE BEEN GIVEN IN ACCORDANCE WITH APPROVED RESOLUTION PLAN / ACCOUNTING STANDARDS

>    Exceptional Items (net) for the year ended 31^st March 2025 comprises of:

The LD charges which has been deducted by the various vendors or government entities in earlier years

has been recovered now after completion of work

>    During the previous year 2023-24 the management has evaluated its investment in subsidiary in UAE and found there is no realizable value from the UAE subsidiary, taking the N CLT order into consideration, the same has been written off along with its provision which were made in the books of accounts and shown as Exceptional Items in the Statement of Profit and Loss Account. Hence, there is no need to prepare the consolidated financial statement/results for the quarter and the year ended March 2024 and onwards.

>    Exceptional Items (net) for the year ended 31^st March 2024 comprises of:

a)    Writing off Loan & Advances Given to Wholly owned Subsidiary situated in UAE. 2.26 crore & Investment made by Rs. 0.54 crore.

b)    Write off provision already provided for in the books of account with respect to the investment made in subsidiary written off during the year by Rs. 4.27 crore.

c)    The above adjustment resulted in the exceptional income of Rs. 1.47 crore

36)    Micro and Small-Scale Business Entities

Under the Micro, Small and Medium Enterprises Development Act, 2006 (MSMED) which came into force from October 2, 2006, certain disclosure are required to be made relating to MSME, On the basis of information and record available with the company, the following disclosure are made for the amounts due to Micro, Small and Medium Enterprises:

(I)    Primary Segment Reporting (Business Segment)

After take over by the management, the company has no reportable segments, hence segment reporting under IND AS 108 is not applicable

(II)    Employee Benefit Expenses

Since there is no employee with a continuous service for more than 5 years, hence no actuarial valuation for leave encashment and gratuity has been done.

42) Capital Management

For the purposes of Company’s capital management, Capital includes equity attributable to the equity holders of the Company and all other equity reserves. The Company manages its capital to ensure that the company will be able to continue as going concerns while maximizing the return to stakeholders through the optimization of the debt and equity balance.

The capital structure of the Company consists of net debt (borrowings offset by cash and bank balances) and total equity of the company.

The Company reviews the capital structure of the Company on a semi-annual basis. As part of this review, the company considers the cost of capital and the risks associated with each class of capital.

45) Financial risk management objectives and policies

The Company’s principal financial liabilities, comprise loans and borrowings, trade and other payables. The main purpose of these financial liabilities is to finance the Company’s operations. The Company's principal financial assets include loans, trade and other receivables and cash and cash equivalents that are derived directly from its operations.

The Company's financial risk management is an integral part of how to plan and execute its business strategies. The Company is exposed to market risk, credit risk and liquidity risk. The company’s focus is to foresee the unpredictability of financial markets and seek to minimize potential adverse effects on its financial performance. The Board of Directors reviews and agrees policies for managing each of these risks which are summarized as below

a)    Market risk

Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises three types of risk: currency rate risk, interest rate risk and other price risks, such as equity price risk and commodity price risk.

i)    Currency rate risk

Foreign currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. The Company's exposure to the risk of changes in foreign exchange rates relates primarily to the Company's operating activities (when revenue or expense is denominated in foreign currency). The exchange rate between the rupee and foreign currencies has changed substantially in recent years and may fluctuate substantially in the future. Consequently, the results of the Company's operations are adversely affected as the rupee appreciates/ depreciates against these currencies

ii)    Interest rate risk

Interest rate is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company’s exposure to the risk of changes in market interest rates relates primarily to the Company's long-term debt obligation at floating interest rates. The Company's borrowings outstanding as at March 31, 2025 is without interest and accordingly, are not expose to risk of fluctuation in market interest rate.

iii)    Commodity price risk

The Company is affected by the price volatility of certain commodities. Its operating activities require the ongoing manufacture of pipe, pole and industrial and domestic air conditioners and therefore require a continuous supply of iron and copper and Aluminum being the major input used in the manufacturing. Due to the significantly increased volatility of the price of the Iron, Copper and aluminum, the Company has entered into various purchase contracts for these material for which there is an active market The Company's Board of Directors has developed and enacted a risk management strategy regarding commodity price risk and its mitigation. The Company partly mitigated the risk of price volatility by entering into the contract for the purchase of these material based on average price of for each month.

b)    Credit risk

Credit Risk is the risk that the counter party will not meet its obligation under a financial instrument or customer contract, leading to a financial loss. The maximum exposure to the credit risk at the reporting date is primarily from trade receivables. Trade receivables are typically unsecured and are derived from revenue earned from customers.

Customer credit risk is managed subject to the Company's established policy, procedures and control relating to customer credit risk management Credit quality of a customer is assessed based on an extensive credit rating scorecard and individual credit limits are defined in accordance with this assessment

c)    Liquidity risk

Liquidity risk is defined as the risk that the Company will not be able to settle or meet its obligations on time. The

Company’s objective is to at all times maintain optimum levels of liquidity to meet its cash and liquidity requirements. The Company closely monitors its liquidity position and deploys a robust cash management system. It maintains adequate source of financing through the use of short-term bank deposits and cash credit facility. Processes and policies related to such risks are overseen by senior management Management monitors the Company’s liquidity position through rolling forecasts on the basis of expected cash flows. The Company assessed the concentration of risk with respect to its debt and concluded it to be low.

The following tables detail the Company's remaining contractual maturity for its non-derivative financial liabilities with agreed repayment periods

49)    After takeover by the new management, the Fixed Assets taken is as per new management best estimate and physical verification/inspection done by the management and FAR has been maintained as per revised life of the assets as per management best estimate and any addition done after takeover by the new management has been duly maintained as per Schedule II of the Company Act. After the corporate insolvency resolution process, no intangible assets has been handed over to new management, accordingly the same has been impaired in the books of accounts in the year 2022. The Fixed Asset Register maintained by company is now comparable with the existing assets. The management verify the tangible recorded assets in fixed assets register in regular interval of time.

50)    After the corporate insolvency resolution process, inventory taken in the books of accounts is as per the new management best estimate and physical verification/inspection done by the management's team and as per valuation done according to IND As-2.

53) Previous year’s figures re-grouped / re-arranged where found necessary. All the figures mentioned are in Rs. Crores except otherwise specifically mentioned therein.